N/A
N=252
Community Support Program for Lung Cancer Screening Volume II
Lung Cancer
Bottom Line
View on ClinicalTrials.gov: NCT06628167 ↗Enrolled (actual)
252
Serious AEs
—
Results posted
Mar 2026
Primary outcome: Primary: Scheduled Lung Cancer Screening Appointments Attended by Participants — 21; 65; 59 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Transportation (Behavioral); Scheduling (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Primary completion
- Feb 2026
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Scheduled Lung Cancer Screening Appointments Attended by Participants |
21; 65; 59 | — |
| SECONDARY CSP Enrollment |
34 | — |
Summary
This is a West Philadelphia based community project to improve adherence to lung cancer screening. The overall objective of this project is to demonstrate the impact of a community support program (CSP) on improve adherence to LCS follow-up guidelines in an urban environment. The study will target individuals in the Penn Medicine healthcare system residing in Philadelphia with an upcoming or missed follow-up screening or orders placed but who have not yet scheduled their screenings by offering free transportation coordination to and from the appointment. The study team will also offer to connect those with placed but unscheduled low dose CT orders to connect with Penn Medicine's scheduling staff.
Eligibility Criteria
Inclusion Criteria
- Upcoming or missed low dose CT for lung cancer screening
- Philadelphia resident
Exclusion Criteria
- Lives outside Philadelphia city limits
Data sourced from ClinicalTrials.gov (NCT06628167). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.